SCHEMBL11223797

SCHEMBL11223797

CC(C)Oc1cc(Cl)ccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 3/20 0.49
CSNK2A1 P68400 2/20 0.46
TP53 P04637 2/20 0.42
RORC P51449 1/20 0.41
HTR2A P28223 2/20 0.41
DRD2 P14416 1/20 0.41
HTR7 P34969 1/20 0.41
HTR6 P50406 1/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
TSHR P16473 1/20 0.40
HTR2C P28335 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10359295 0.83 NOS2 (0.46) NOS2TP53HTR2ADRD2HTR7
SCHEMBL7172382 0.83 CSNK2A1 (0.59) CSNK2A1TP53RORCHTTLMNA
SCHEMBL21340747 0.81 HTR2A (0.47) HTR2AALDH1A1MEN1HPGDKMT2A
SCHEMBL14039634 0.81 CSNK2A1 (0.49) CSNK2A1RORCHTR2ALMNAPOLB
SCHEMBL16606237 0.81 CSNK2A1 (0.44) CSNK2A1RORCHTR2ALMNAPOLB
SCHEMBL25974456 0.81 HTR2A (0.46) CSNK2A1RORCHTR2AHTTLMNA
SCHEMBL19121462 0.79 CSNK2A1 (0.43) NOS2CSNK2A1RORCHTTLMNA
SCHEMBL17744335 0.79 HSD17B10 (0.45) CSNK2A1RORCHTR2AHTTLMNA
SCHEMBL2372500 0.79 CSNK2A1 (0.47) NOS2CSNK2A1RORCHTR2AHTT
SCHEMBL19088280 0.79 TRPV4 (0.46) CSNK2A1TP53HTR2AHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4346244-A Preparation of chloroalkoxybenzenes RHONE-POULENC INDUSTRIES (FR) 1982-08-24 US claimed
US-20190002448-A1 SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF Karyopharm Therapeutics Inc. 2019-01-03 US disclosed
WO-2017117406-A1 SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF Karyopharm Therapeutics Inc. (US) 2017-07-06 WO disclosed
US-4346244-A Preparation of chloroalkoxybenzenes RHONE-POULENC INDUSTRIES (FR) 1982-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190002448-A1 SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF BCL6, MALT1, BCL3 NOS2 4701/4885CSNK2A1 856/4885TP53 684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.